<DOC>
	<DOCNO>NCT02104882</DOCNO>
	<brief_summary>Glioblastoma multiforme ( GBM ) disease extremely poor prognosis . Despite surgery radiochemotherapy , tumor likely grow back quickly . Intraoperative radiotherapy ( IORT ) may improve local control rate spar healthy tissue ( Giordano et al . 2014 ) . IORT take place cranioplasty directly gross ( subtotal ) tumor resection . Several past study IORT GBM conduct Japan Spain yield encouraging result ( Sakai et al . 1989 ; Matsutani et al . 1994 ; Fujiwara et al . 1995 ; Ortiz de Urbina et al . 1995 ) . However , full potential procedure date largely unexplored previous study use forward-scattering ( electron-based ) irradiation technique , frequently lead inadequately cover target volume . With advent spherically irradiation device Intrabeam® system ( Carl Zeiss Meditec AG , Oberkochen , Germany ) , even complex cavity adequately cover irradiation IORT . However , data maximum tolerate dose IORT low-energy X-rays generate system . The INTRAGO I/II study aim find dose single shot radiation , deliver intraoperatively direct surgery , tolerable patient GBM . A secondary goal study find whether procedure may improve survival rate .</brief_summary>
	<brief_title>INTRAGO-Intraoperative Radiotherapy Glioblastoma - Phase I/II Study</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Histologically confirm glioblastoma multiforme frozen section Age ≥50 year Karnofsky Performance Index ≥ 50 % Informed consent Adequate birth control ( e.g. , oral contraceptive ) Astrocytoma ≤ WHO grade III Gliomatosis cerebri Multifocal lesion Infratentorial localization Previous cranial radiation therapy ( location ) Uncontrolled intercurrent illness include , limited , ongoing active infection psychiatric illness/social situation would limit compliance study requirement . Contraindications general anaesthesia Bleeding clotting disorder Contraindications MRI CT scan Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Glioblastoma Multiforme</keyword>
	<keyword>High-Grade Glioma</keyword>
	<keyword>Malignant Glioma</keyword>
	<keyword>IORT</keyword>
</DOC>